Genesis Laboratories, Inc.

Wellington, CO

UEI
Q2RAMBFQRBV4
CAGE
3A0Y6
Primary NAICS
541690 Other Scientific and Technical Consulting Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
10122 NE Frontage Rd, Wellington, CO 80549, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Genesis Laboratories, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Field trial of fipronil-laced oral bait Contract · 75D30123C17159 CDC Pittsburgh $620,310
Field trial of fipronil laced bit to control ixodes scapularis immature as rodents Contract · 75D30121P12632 CDC Pittsburgh $249,940
A mineral lick to white tailed deer to systematically control black legged ticks & reduce lyme disease Contract · 75D30120C09834 CDC Pittsburgh $570,429
2020 BAA Contract · 75D30120C08427 CDC Pittsburgh $149,147
Spatial repellent system for long-term, passive release, for the deployed warfighter protection. Grant · W911QY1510001 ACC Aberdeen Proving Ground $919,000

About Genesis Laboratories, Inc.

Genesis Laboratories, Inc. is a for-profit, subchapter S corporation that provides products and services related to vector-borne disease research and prevention to the Centers for Disease Control and Prevention (CDC). As a registered corporate entity in SAM.gov since 2002, Genesis Laboratories has been awarded multiple federal contracts from the CDC to conduct field trials, provide bait products, and distribute mineral licks intended to control tick populations and Lyme disease incidence.

Through past prime federal contracts, Genesis Laboratories has provided fipronil-laced oral bait products and conducted related field trials in Colorado for the CDC's vector-borne disease program, as well as supplied mineral licks to systematically control black-legged ticks and reduce Lyme disease among white-tailed deer populations. The company was also awarded a CDC contract in 2020 to study methods of controlling immature Ixodes scapularis ticks in rodents. No set aside designations were associated with these awards, which ranged from $149,147 to $620,310 in value under purchase order, definitive, and Basic Ordering Agreement contract types.

SBA capabilities narrative

Ecotox testing for pesticide safety on wildlife. Wildlife diseases research, rodent and repellents r&d, formulation development, analytical chemistry, field studies, radio tags on birds, rodents, bats, turtles, pigs, cervids, and other wildlife.

Quick answers

What is Genesis Laboratories, Inc.'s UEI?

Genesis Laboratories, Inc.'s Unique Entity ID (UEI) in SAM.gov is Q2RAMBFQRBV4.

What is Genesis Laboratories, Inc.'s CAGE code?

Genesis Laboratories, Inc.'s CAGE code is 3A0Y6.

What is Genesis Laboratories, Inc.'s primary NAICS code?

Genesis Laboratories, Inc.'s primary NAICS code is 541690 (Other Scientific and Technical Consulting Services).

Where is Genesis Laboratories, Inc. located?

Genesis Laboratories, Inc.'s physical address in SAM.gov is 10122 NE Frontage Rd, Wellington, CO 80549, USA.

Is Genesis Laboratories, Inc. registered in SAM.gov?

Yes. Genesis Laboratories, Inc.'s SAM.gov registration is active through April 13, 2027.

What is Genesis Laboratories, Inc.'s most recent federal award?

Genesis Laboratories, Inc.'s most recent federal contract award is Field trial of fipronil-laced oral bait (75D30123C17159), from CDC Pittsburgh, on August 25, 2023.

On GovTribe

See Genesis Laboratories, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors